• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄斑下出血:视力预后及预后因素

Submacular Hemorrhage: Visual Outcomes and Prognostic Factors.

作者信息

Kunavisarut Paradee, Thithuan Tipparut, Patikulsila Direk, Choovuthayakorn Janejit, Watanachai Nawat, Chaikitmongkol Voraporn, Pathanapitoon Kessara, Rothova Aniki

机构信息

Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

Asia Pac J Ophthalmol (Phila). 2018 Mar-Apr;7(2):109-113. doi: 10.22608/APO.2017389. Epub 2017 Oct 23.

DOI:10.22608/APO.2017389
PMID:29063740
Abstract

PURPOSE

To describe causes, visual outcomes, and prognostic factors in patients with submacular hemorrhage (SMH).

DESIGN

Retrospective case review.

METHODS

We performed a retrospective review of SMH with a size of at least 1 disc diameter. SMH causes were classified into 3 groups: 1) neovascular age-related macular degeneration (nAMD), 2) polypoidal choroidal vasculopathy (PCV), and 3) other miscellaneous causes.

RESULTS

Ninety-eight eyes of 98 patients were included. Based on clinical presentation and indocyanine green angiography (ICGA), the diagnoses of PCV (59%), nAMD (31%), and miscellaneous other causes (10%) were made. PCV patients were younger (P = 0.005) and had larger SMH size than nAMD patients (P = 0.008). Poor visual outcome [>1.0 logarithm of the minimum angle of resolution (logMAR)] at 6 months was associated with low initial visual acuity (VA; >1.0 logMAR; P = 0.002) and with the diagnosis of nAMD (P = 0.02). In addition, limited visual outcomes were noted for patients older than 65 years and those with persistent SMH for at least 2 months.

CONCLUSIONS

PCV was the most common cause of SMH in Thailand. ICGA represented a valuable tool for the diagnosis. Visual outcomes were limited for patients with nAMD and for patients who presented with poor initial VA.

摘要

目的

描述黄斑下出血(SMH)患者的病因、视力预后及预后因素。

设计

回顾性病例研究。

方法

我们对大小至少为1个视盘直径的SMH进行了回顾性研究。SMH病因分为3组:1)新生血管性年龄相关性黄斑变性(nAMD),2)息肉状脉络膜血管病变(PCV),3)其他杂类病因。

结果

纳入98例患者的98只眼。根据临床表现和吲哚菁绿血管造影(ICGA),做出PCV(59%)、nAMD(31%)和其他杂类病因(10%)的诊断。PCV患者比nAMD患者年轻(P = 0.005),SMH面积更大(P = 0.008)。6个月时视力预后差[最小分辨角对数(logMAR)>1.0]与初始视力低(VA;>1.0 logMAR;P = 0.002)及nAMD诊断相关(P = 0.02)。此外,65岁以上患者及SMH持续至少2个月的患者视力预后有限。

结论

PCV是泰国SMH最常见的病因。ICGA是一种有价值的诊断工具。nAMD患者及初始视力差的患者视力预后有限。

相似文献

1
Submacular Hemorrhage: Visual Outcomes and Prognostic Factors.黄斑下出血:视力预后及预后因素
Asia Pac J Ophthalmol (Phila). 2018 Mar-Apr;7(2):109-113. doi: 10.22608/APO.2017389. Epub 2017 Oct 23.
2
Identification of Underlying Causes of Spontaneous Submacular Hemorrhage by Indocyanine Green Angiography.通过吲哚菁绿血管造影术识别自发性黄斑下出血的潜在病因
Ophthalmologica. 2015;233(3-4):146-54. doi: 10.1159/000380830. Epub 2015 Mar 26.
3
Incidence Rate of Massive Submacular Hemorrhage and its Risk Factors in Polypoidal Choroidal Vasculopathy.息肉状脉络膜血管病变中大量黄斑下出血的发病率及其危险因素
Am J Ophthalmol. 2016 Sep;169:79-88. doi: 10.1016/j.ajo.2016.06.014. Epub 2016 Jun 16.
4
Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular degeneration.息肉样脉络膜血管病变与典型新生血管性年龄相关性黄斑变性的巨大黄斑下出血。
Acta Ophthalmol. 2021 Aug;99(5):e706-e714. doi: 10.1111/aos.14676. Epub 2020 Dec 2.
5
Characteristics of Submacular Hemorrhages in Age-Related Macular Degeneration.年龄相关性黄斑变性中黄斑下出血的特征
Optom Vis Sci. 2017 May;94(5):556-563. doi: 10.1097/OPX.0000000000001066.
6
Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization.眼内抗血管内皮生长因子治疗脉络膜新生血管性黄斑下出血。
Ophthalmology. 2014 Apr;121(4):926-35. doi: 10.1016/j.ophtha.2013.11.004. Epub 2013 Dec 15.
7
Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy.年龄相关性黄斑变性或息肉样脉络膜血管病变继发黄斑下出血眼的 6 个月视力预后。
Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):19-25. doi: 10.1007/s00417-012-2029-1. Epub 2012 May 26.
8
Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.眼内组织型纤溶酶原激活物、雷珠单抗联合气体注射治疗息肉样脉络膜血管病变伴黄斑下出血
Ophthalmology. 2016 Jun;123(6):1278-86. doi: 10.1016/j.ophtha.2016.01.035. Epub 2016 Mar 2.
9
Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.息肉样脉络膜血管病变继发黄斑下出血消退后视网膜变化的量化分析
Jpn J Ophthalmol. 2018 Jan;62(1):54-62. doi: 10.1007/s10384-017-0549-2. Epub 2017 Nov 29.
10
Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.序贯组织型纤溶酶原激活剂、气体置换及抗血管内皮生长因子治疗黄斑下出血
Eur J Ophthalmol. 2018 May;28(3):306-310. doi: 10.5301/ejo.5001074.

引用本文的文献

1
Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhage.玻璃体切割联合组织型纤溶酶原激活剂治疗外伤性黄斑下出血。
Int J Ophthalmol. 2025 Sep 18;18(9):1797-1802. doi: 10.18240/ijo.2025.09.22. eCollection 2025.
2
Predictive Factors for Submacular Hemorrhage in Age-related Macular Degeneration: A Retrospective Study.年龄相关性黄斑变性患者黄斑下出血的预测因素:一项回顾性研究
Korean J Ophthalmol. 2024 Dec;38(6):471-479. doi: 10.3341/kjo.2024.0032. Epub 2024 Oct 22.
3
Development and validation of optical coherence tomography (OCT) and OCT angiography prediction model for short-term vitreous haemorrhage secondary to polypoidal choroidal vasculopathy.
息肉样脉络膜血管病变继发短期玻璃体积血的光学相干断层扫描(OCT)及OCT血管造影预测模型的开发与验证
Br J Ophthalmol. 2025 Feb 24;109(3):391-400. doi: 10.1136/bjo-2024-325246.
4
Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis.组织型纤溶酶原激活剂联合抗血管内皮生长因子药物治疗黄斑下出血的疗效评估:一项Meta分析
J Clin Med. 2023 Jan 29;12(3):1035. doi: 10.3390/jcm12031035.
5
Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degeneration.抗血小板和抗凝治疗新生血管性年龄相关性黄斑变性导致的黄斑下出血。
Graefes Arch Clin Exp Ophthalmol. 2023 May;261(5):1413-1421. doi: 10.1007/s00417-022-05885-2. Epub 2022 Nov 29.
6
Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry.在日常临床实践中,新生血管性年龄相关性黄斑变性导致视力丧失的黄斑下出血的发生率、风险因素和结局:FRB! 注册研究的数据。
Acta Ophthalmol. 2022 Dec;100(8):e1569-e1578. doi: 10.1111/aos.15137. Epub 2022 Mar 23.
7
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.玻璃体切除术、视网膜下组织纤维蛋白溶酶原激活物和眼内气体治疗渗出性年龄相关性黄斑变性继发的黄斑下出血(TIGER):一项 3 期、泛欧、2 组、非商业、活性对照、观察者设盲、优效性、随机对照手术试验的研究方案。
Trials. 2022 Jan 31;23(1):99. doi: 10.1186/s13063-021-05966-3.
8
Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration.经瞳孔温热疗法联合贝伐单抗眼内注射治疗脉络膜新生血管性年龄相关性黄斑变性继发黄斑下出血
Turk J Ophthalmol. 2021 Feb 25;51(1):38-44. doi: 10.4274/tjo.galenos.2020.72540.
9
Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration.与年龄相关性黄斑变性相关的黄斑下出血经玻璃体腔内组织型纤溶酶原激活物和气体注射后发生玻璃体积血突破的危险因素。
PLoS One. 2020 Dec 3;15(12):e0243201. doi: 10.1371/journal.pone.0243201. eCollection 2020.
10
Traumatic submacular hemorrhage: available treatment options and synthesis of the literature.创伤性黄斑下出血:可用的治疗选择及文献综述
Int J Retina Vitreous. 2019 Dec 11;5:48. doi: 10.1186/s40942-019-0200-0. eCollection 2019.